Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
safety profile
Pharma
Apellis homes in on possible source of rare Syfovre side effect
While nothing is certain yet, Apellis may be homing in on the source of a rare but serious side effect tied to its geographic atrophy drug Syfovre.
Fraiser Kansteiner
Aug 23, 2023 9:28am
Apellis bolsters case for Syfovre amid second-quarter earnings
Jul 31, 2023 9:58am
Experts report eye inflammation cases linked to Apellis' Syfovre
Jul 17, 2023 5:30pm
